Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibility

The incidence of variant Creutzfeldt–Jakob disease (vCJD) in the United Kingdom appears to be in decline, with only four deaths reported this year (to 6 September 2004). However, results of a survey of lymphoreticular tissues have suggested a substantially higher prevalence of vCJD than expected from the clinical data alone. There are two plausible explanations for this discrepancy: first, a proportion of those infected will not develop clinical disease (subclinical infection); and second, the genetic group in which no clinical cases of vCJD have yet occurred is susceptible. Using mathematical models for the primary transmission of bovine spongiform encephalopathy to humans, we explore the impact of these hypotheses on case predictions. Under the first hypothesis, the results suggest relatively few future cases will arise via primary transmission, but that these cases are a small proportion of those infected, with most having subclinical infection. Under the second hypothesis, results suggest a maximum fivefold increase in cases, but this hypothesis is unable to account for the discrepancy between clinical cases and the estimated prevalence. Predictions of future cases of vCJD therefore remain uncertain, particularly given the recent identification of additional cases infected via blood transfusion.

[1]  J. Zajicek,et al.  Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease , 1998, The Lancet.

[2]  J Collinge,et al.  Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. , 1999, Science.

[3]  S. Bird,et al.  UK dietary exposure to BSE in head meat: by birth cohort and gender. , 2002, Journal of cancer epidemiology and prevention.

[4]  L. McShane,et al.  Iatrogenic Creutzfeldt–Jakob disease at the millennium , 2000, Neurology.

[5]  M. Alpers,et al.  Increased susceptibility to Kuru of carriers of the PRNP 129 methionine/methionine genotype. , 2001, The Journal of infectious diseases.

[6]  C. Wiley,et al.  Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt–Jakob disease , 2004, Journal of Clinical Pathology.

[7]  Christl A Donnelly,et al.  Factors determining the pattern of the variant Creutzfeldt-Jakob disease (vCJD) epidemic in the UK , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[8]  Cooper Jd,et al.  UK bovine carcass meat consumed as burgers, sausages and other meat products: by birth cohort and gender. , 2002 .

[9]  Andrew F. Hill,et al.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.

[10]  T. Crow,et al.  Codon 129 changes in the prion protein gene in Caucasians. , 1990, American journal of human genetics.

[11]  J. Miller,et al.  Preclinical Diagnosis of Scrapie by Immunohistochemistry of Third Eyelid Lymphoid Tissue , 2000, Journal of Clinical Microbiology.

[12]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. De Angelis,et al.  Prevalence of detectable abnormal prion protein in persons incubating vCJD: plausible incubation periods and cautious inference. , 2000, Journal of epidemiology and biostatistics.

[14]  A. Ghani,et al.  Retrospective study of prion-protein accumulation in tonsil and appendix tissues , 2000, The Lancet.

[15]  A. Ghani,et al.  Estimating the human health risk from possible BSE infection of the British sheep flock , 2002, Nature.

[16]  Pandu R. Tadikamalla,et al.  A Probability Distribution and its Uses in Fitting Data , 1979 .

[17]  N M Ferguson,et al.  Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain , 1998, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[18]  S. Bird,et al.  Predicting incidence of variant Creutzfeldt-Jakob disease from UK dietary exposure to bovine spongiform encephalopathy for the 1940 to 1969 and post-1969 birth cohorts. , 2003, International journal of epidemiology.

[19]  Christl A. Donnelly,et al.  Predicted vCJD mortality in Great Britain , 2000, Nature.

[20]  J. Collinge,et al.  Subclinical prion infection in humans and animals. , 2003, British medical bulletin.

[21]  S. Cousens,et al.  Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent , 1997, Nature.

[22]  Mark Penney,et al.  Prevalence of lymphoreticular prion protein accumulation in UK tissue samples , 2004, The Journal of pathology.

[23]  M. Head,et al.  Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004, The Lancet.

[24]  A. Valleron,et al.  Estimation of Epidemic Size and Incubation Time Based on Age Characteristics of vCJD in the United Kingdom , 2001, Science.

[25]  A. Hofman,et al.  A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.

[26]  S. Bird,et al.  UK bovine carcass meat consumed as burgers, sausages and other meat products: by birth cohort and gender. , 2002, Journal of cancer epidemiology and prevention.

[27]  Markus Glatzel,et al.  Plasminogen binds to disease-associated prion protein of multiple species , 2001, The Lancet.

[28]  Cooper Jd,et al.  UK dietary exposure to BSE in head meat: by birth cohort and gender. , 2002 .

[29]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[30]  J. Collinge,et al.  BSE prions propagate as either variant CJD‐like or sporadic CJD‐like prion strains in transgenic mice expressing human prion protein , 2002, The EMBO journal.

[31]  P. Brown,et al.  Phenotype-genotype studies in kuru: implications for new variant Creutzfeldt-Jakob disease. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Cousens,et al.  Predictability of the UK Variant Creutzfeldt-Jakob Disease Epidemic , 2001, Science.

[33]  V. Isham,et al.  Estimation of the incidence of HIV infection. , 1989, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[34]  William H. Press,et al.  Numerical recipes in C , 2002 .

[35]  J Mackenzie,et al.  Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion , 2004, The Lancet.

[36]  M. Palmer,et al.  Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease , 1991, The Lancet.

[37]  Mark Head,et al.  Preclinical variant CJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004 .

[38]  E. Williams,et al.  Active Surveillance for Scrapie by Third Eyelid Biopsy and Genetic Susceptibility Testing of Flocks of Sheep in Wyoming , 2002, Clinical and Vaccine Immunology.

[39]  A. Ghani,et al.  Accumulation of prion protein in tonsil and appendix: review of tissue samples , 2002, BMJ : British Medical Journal.

[40]  M. Smits,et al.  Tonsillar biopsy and PrPSc detection in the preclinical diagnosis of scrapie , 1998, Veterinary Record.

[41]  A. Ghani,et al.  Updated projections of future vCJD deaths in the UK , 2003 .

[42]  Jean Maccario,et al.  The Incubation Period of Kuru , 2002, Epidemiology.

[43]  A. Alpérovitch,et al.  Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease , 1999, The Lancet.